US FDA concerned over potential Novavax myocarditis risk
The Food and Drug Administration voiced concern Friday about myocarditis being potentially linked to the Novavax Covid-19 vaccine, just as ...
Read moreThe Food and Drug Administration voiced concern Friday about myocarditis being potentially linked to the Novavax Covid-19 vaccine, just as ...
Read moreIndonesia, hard-hit by the coronavirus pandemic, became the first country to approve the new vaccine for COVID-19 created by US-based ...
Read moreThe COVID-19 vaccine NVX-Cov2373 developed by Novavax, a US biotechnology company, demonstrated a 92.6% efficacy against variants of concern and ...
Read more"‹Millions of Filipinos stand to benefit from the results of Covovax licensed by Novavax following the global announcement of final ...
Read moreUS biotech firm Novavax on Monday said it had delayed plans to seek authorization for its COVID vaccine candidate, a ...
Read moreUS biotech firm Novavax said Monday it had started clinical trials of its proposed COVID-19 vaccine on children, in a ...
Read moreThe Philippines has secured 30 million doses of the COVID-19 vaccine developed by US biotech firm Novavax Inc, an official ...
Read moreThe government is set to sign today an agreement with US biotech company Novavax for 30 million doses of its ...
Read more"Even if we do get inoculated, we should still remain careful." With the arrival of close to a million ...
Read moreUS biotech company Novavax said Monday it hopes to file for British approval of its COVID-19 vaccine at the start ...
Read moreIn tone and content, the online edition mirrors the editorial thrust of the newspaper. While hewing to the traditional precepts of fairness and objectivity, MS believes the news of the day need not be staid, overly long or dry. Stories are succinct, readable and written in a lively style that has become a hallmark of the newspaper.
6th Floor Universal Re Bldg., 106 Paseo De Roxas cor. Perea Street, Legaspi Village, 1226 Makati City Philippines
Trunklines: 832-5554, 832-5556, 832-5558
© 2021 Manila Standard - Designed and Developed by Neitiviti Studios.
© 2021 Manila Standard - Designed and Developed by Neitiviti Studios.